Stocks / Biotech

ABVXBiotech

Abivax SA
$106.991d +4.4%5d -7.8%settled close · 2026-09-17
Mkt cap $8.7B (3/25)β 1.1052w $75–145Shares 79.2MNasdaq since 2023Emp. 67abivax.com
The tape, with the calls on it

Who said what, and what ABVX did next

Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.

bullish bearish both sides
Who’s talkingIdea Scout · free

Who’s talking about ABVX

2 longlatest 2026-06-10
DateVoiceStanceVenueThesis
2026-06-10Adam MayPhysician & Biotech InvestorBullishYet Another Value PodcastMaintenance data blew out expectations — 40% clinical remission delta and double Rinvoq's endoscopic…
2026-03-23Adam MayPhysician & Biotech InvestorBullishYet Another Value PodcastAbivax's obefazimod is the most obvious buyout candidate Adam has seen—post-phase-3 with unique unknown…
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
The options tape

Notable options days

Sessions in the last 120 where ABVX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-16
2026-08-21
2026-08-20
2026-06-30
2026-06-24
2026-06-03
2026-06-02
2026-04-14
2026-03-27
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on ABVX is in this morning’s Brief. Get The Brief — $20/mo →